Thrombosis and Haemostasis · 2004 · 28 citations · 14 references
MedicineNeurologyPharmacotherapyAutoimmunityClinical ImmunologyRheumatologyDeep Vein ThrombosisImmunosuppressionPulmonary EmbolismThromboembolic DiseaseThrombosisVenous ThromboembolismDeep Vein Thrombosis EvaluationImmunosuppressive CompoundsMitoxantrone TherapyMultiple Sclerosis ImmunopathogenesisMultiple Sclerosis ImmunopathologyMultiple Sclerosis TherapyRelapsing-remitting Multiple Sclerosis TreatmentVenous Thromboembolism Assessment
A 38-year-old woman reported a 2-day history of pain at the base of the thigh and progressive non-pitting edema of the left lower limb. She did not complain of symptoms suggestive of pulmonary embolism. Her past medical history did not reveal venous thromboembolism risk factors, but the use of oral contraceptives. She had relapsing-remitting multiple sclerosis (MS) which had been evolving since 1986, treated by interferon beta1a. The secondary progressive form occurred after 12 years, requiring immunosuppressive drugs such as cyclophosphamide, then mitoxantrone. Since they were successively ineffective in stopping disease progression, intravenous immunoglobulins (IVIg) were tried as a rescue treatment. . . .
14
High‐dose intravenous immunoglobulin and serum viscosity
Marinos C. Dalakas · Neurology · 1994 · 271 citations
Life Sciences, Immunology, Neurology +10
Effects of Corticosteroids on Coagulation of the Blood
Şînasi Özsoylu, Herbert S. Strauss, Louis K. Diamond · Nature · 1962 · 148 citations